← back to search

Jakob Trimpert

Institute of Virology of the Slovak Academy of Sciences · US
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Herpesvirus Infections and Treatments, and Cytomegalovirus and herpesvirus research.
h-index
33
citations
4,233
works
148
NIH funding
primary concept
Biology
email

Recent publications

Rewired type I IFN signaling is linked to age-dependent differences in COVID-19
Cell Reports Medicine 2025cited by 3position: middledoi
Polysialosides Outperform Sulfated Analogs for Binding with SARS‐CoV‐2
Small 2025cited by 0position: middledoi
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Nature Communications 2024cited by 32position: lastdoi
Mucus‐Inspired Self‐Healing Hydrogels: A Protective Barrier for Cells against Viral Infection
Advanced Materials 2024cited by 29position: middledoi
Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants
Proceedings of the National Academy of Sciences 2024cited by 15position: middledoi
Single-cell-resolved interspecies comparison shows a shared inflammatory axis and a dominant neutrophil-endothelial program in severe COVID-19
Cell Reports 2024cited by 6position: middledoi
Neural network-assisted humanisation of COVID-19 hamster transcriptomic data reveals matching severity states in human disease
EBioMedicine 2024cited by 4position: middledoi
Protective role of the HSP90 inhibitor, STA-9090, in lungs of SARS-CoV-2-infected Syrian golden hamsters
BMJ Open Respiratory Research 2024cited by 3position: middledoi
Polysialosides outperform sulfated analogs for the inhibition of SARS-CoV-2
ChemRxiv 2024cited by 0position: middledoi
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
Nature Microbiology 2023cited by 79position: lastdoi
In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs® 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2
Frontiers in Pharmacology 2023cited by 11position: middledoi
Early protective effect of a (“pan”) coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration
Frontiers in Immunology 2023cited by 10position: middledoi
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion
EMBO Reports 2022cited by 126position: middledoi
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
Nature Biotechnology 2022cited by 59position: lastdoi
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication <i>In Vitro</i> and Decreases Viral Titers and Disease Progression in Syrian Hamsters
mBio 2022cited by 41position: middledoi
Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics
Molecular Therapy 2022cited by 33position: lastdoi
SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression
PLoS Biology 2022cited by 29position: middledoi
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics
European Respiratory Review 2022cited by 14position: middledoi
Protocol to dissociate healthy and infected murine- and hamster-derived lung tissue for single-cell transcriptome analysis
STAR Protocols 2022cited by 7position: middledoi
SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals
Nature Communications 2021cited by 288position: middledoi
ICTV Virus Taxonomy Profile: Herpesviridae 2021
Journal of General Virology 2021cited by 242position: middledoi
Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19
Nature Communications 2021cited by 101position: middledoi
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2
Scientific Reports 2021cited by 97position: middledoi
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
Cell 2020cited by 385position: middledoi
Mechanism of Virus Attenuation by Codon Pair Deoptimization
Cell Reports 2020cited by 88position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Julia M. Adler · Robert Koch Institute9 papers (2022–2024)Emanuel Wyler · Institute of Virology of the Slovak Academy of Sciences8 papers (2020–2024)Geraldine Nouailles · Humboldt-Universität zu Berlin7 papers (2021–2024)Markus Landthaler · Institute for Medical Biology7 papers (2020–2024)Achim D. Gruber · Technische Universität Berlin6 papers (2021–2024)Peter Pennitz · Humboldt-Universität zu Berlin6 papers (2021–2024)Daria Vladimirova · Freie Universität Berlin5 papers (2021–2024)Martin Witzenrath · German Centre for Cardiovascular Research5 papers (2021–2024)Christine Goffinet · Sunshine Coast University Hospital4 papers (2021–2024)Christian Drosten · University of Edinburgh4 papers (2021–2025)Dylan Postmus · Liverpool School of Tropical Medicine4 papers (2021–2024)Fabian Pott · Institute of Virology of the Slovak Academy of Sciences4 papers (2021–2024)Kai Ludwig · Freie Universität Berlin3 papers (2024–2025)Rainer Haag · Freie Universität Berlin3 papers (2024–2025)Daniela Niemeyer · Humboldt-Universität zu Berlin3 papers (2024–2025)Julia Kazmierski · Institute of Virology of the Slovak Academy of Sciences3 papers (2021–2024)Luiz Gustavo Teixeira Alves · Max Delbrück Center3 papers (2024–2024)Yannic Kerkhoff · Freie Universität Berlin3 papers (2024–2025)Christine Langner · Freie Universität Berlin3 papers (2024–2024)Cengiz Goekeri · Humboldt-Universität zu Berlin3 papers (2022–2024)